IL7 and leukemia: Moreover, these mAb chimeras inhibit IL-7R signaling at low IL-7 concentrations, mediate antibody-dependent cell mediated cytotoxicity in vitro and are effective in controlling established and relapsing leukemia in vivo (139) (Table 2).